Skip to content

Clinical trials

Observational Hepatitis C trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Observational Country / region: Australia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20111
20125
20142
20153
20161
20191
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status5
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kirby Institute7
Gilead Sciences4
Bayside Health2
Bristol-Myers Squibb2
FixHepC1
Fremantle Hospital and Health Service1
Garvan Institute of Medical Research1
Macfarlane Burnet Institute for Medical Research and Public Health Ltd1
University Paris 7 - Denis Diderot1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C20
HIV Infections2
Hepatitis C, Chronic2
Acquired Immunodeficiency Syndrome1
Bronchiolitis Obliterans Syndrome1
Digestive System Diseases1
Fatty Liver1
Fibrosis1
Hepatitis1
Hepatitis B1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.